108 related articles for article (PubMed ID: 2969786)
1. Immunological mechanisms of corticosteroid therapy in chronic active hepatitis: analysis of peripheral blood suppressor T-cell and interleukin 2 activities.
Ikeda T; Uchihara M; Daiguji Y; Hasumura Y; Takeuchi J
Clin Immunol Immunopathol; 1988 Sep; 48(3):371-9. PubMed ID: 2969786
[TBL] [Abstract][Full Text] [Related]
2. In vitro effect of prednisolone on peripheral blood suppressor T cell activity in patients with alcoholic hepatitis.
Ikeda T; Daiguji Y; Hasumura Y; Takeuchi J
Clin Immunol Immunopathol; 1989 Nov; 53(2 Pt 1):225-32. PubMed ID: 2529069
[TBL] [Abstract][Full Text] [Related]
3. Effects of immunosuppressive therapy with prednisolone on B and T lymphocyte function in patients with chronic type B hepatitis.
Hanson RG; Peters MG; Hoofnagle JH
Hepatology; 1986; 6(2):173-9. PubMed ID: 2937707
[TBL] [Abstract][Full Text] [Related]
4. In vitro effect of corticosteroid on immunoregulatory functions in primary biliary cirrhosis.
Ikeda T; Uchihara M; Daiguji Y; Hasumura Y; Takeuchi J
Clin Immunol Immunopathol; 1989 Nov; 53(2 Pt 1):192-201. PubMed ID: 2529068
[TBL] [Abstract][Full Text] [Related]
5. IgG production in 'autoimmune' chronic active hepatitis. Effect of prednisolone on T and B lymphocyte function.
Nouri-Aria KT; Hegarty JE; Alexander GJ; Eddleston AL; Williams R
Clin Exp Immunol; 1985 Aug; 61(2):290-6. PubMed ID: 3876182
[TBL] [Abstract][Full Text] [Related]
6. Methotrexate therapy in asthma increases T cell susceptibility to corticosteroid inhibition.
Corrigan CJ; Shiner R; Shakur BH; Ind PW
Clin Exp Allergy; 2003 Aug; 33(8):1090-6. PubMed ID: 12911783
[TBL] [Abstract][Full Text] [Related]
7. Antigen specific suppressor cell function in autoimmune chronic active hepatitis.
Vento S; Hegarty JE; Bottazzo G; Macchia E; Williams R; Eddleston AL
Lancet; 1984 Jun; 1(8388):1200-4. PubMed ID: 6202994
[TBL] [Abstract][Full Text] [Related]
8. Studies of immune functions of patients with chronic hepatitis.
Nonomura A; Tanino M; Kurumaya H; Ohta G; Kato Y; Kobayashi K
Tohoku J Exp Med; 1982 Jun; 137(2):163-77. PubMed ID: 6214045
[TBL] [Abstract][Full Text] [Related]
9. Effect of (+)-cyanidanol-3 (Catergen) in chronic active hepatitis. (Catergen plus prednisolone versus prednisolone in a controlled study).
Pár A; Paál M; Kádas I; Kerekes E; Jávor T
Acta Med Hung; 1983; 40(1):17-24. PubMed ID: 6664741
[TBL] [Abstract][Full Text] [Related]
10. T lymphocyte subpopulations defined by two sets of monoclonal antibodies in chronic active hepatitis and systemic lupus erythematosus.
Frazer IH; Mackay IR
Clin Exp Immunol; 1982 Oct; 50(1):107-14. PubMed ID: 6216997
[TBL] [Abstract][Full Text] [Related]
11. T suppressor cell function and number in children with liver disease.
Nouri-Aria KT; Lobo-Yeo A; Vergani D; Mieli-Vergani G; Eddleston AL; Mowat AP
Clin Exp Immunol; 1985 Aug; 61(2):283-9. PubMed ID: 2931221
[TBL] [Abstract][Full Text] [Related]
12. Relationship between T-lymphocyte subsets and suppressor cell activity in patients with chronic active hepatitis B.
Jang TW; Koo JY; Park BC
Korean J Intern Med; 1989 Jan; 4(1):41-7. PubMed ID: 2535041
[TBL] [Abstract][Full Text] [Related]
13. In vitro effect of TP-1 (a calf thymic extract) on suppressor T-cell function of patients with autoimmune chronic active hepatitis.
O'Brien CJ; Nouri-Aria KT; Hegarty JE; Vento S; Eddleston AL; Williams R
Int J Immunopharmacol; 1988; 10(6):651-6. PubMed ID: 2974021
[TBL] [Abstract][Full Text] [Related]
14. Preferential activation of helper/inducer T lymphocytes in autoimmune chronic active hepatitis.
Lobo-Yeo A; Alviggi L; Mieli-Vergani G; Portmann B; Mowat AP; Vergani D
Clin Exp Immunol; 1987 Jan; 67(1):95-104. PubMed ID: 2957133
[TBL] [Abstract][Full Text] [Related]
15. Disordered immunoregulatory functions in patients with chronic active hepatitis.
Nonomura A; Tanino M; Kurumaya H; Ohta G; Kato Y; Kobayashi K
Clin Exp Immunol; 1982 Mar; 47(3):595-605. PubMed ID: 6211306
[TBL] [Abstract][Full Text] [Related]
16. Serial observation of lymphocyte subpopulations and interleukin 2 production of T cells from patients with acute viral hepatitis and chronic active hepatitis.
Onji M; Kondo H; Ohta Y
Hepatogastroenterology; 1988 Feb; 35(1):10-3. PubMed ID: 3129350
[TBL] [Abstract][Full Text] [Related]
17. Increased thymic hormone responsive suppressor T lymphocyte function in chronic active hepatitis.
Mutchnick MG; Schaffner JA; Prieto JA; Weller FE; Goldstein AL
Dig Dis Sci; 1983 Apr; 28(4):328-34. PubMed ID: 6219866
[TBL] [Abstract][Full Text] [Related]
18. Functional characterization of peripheral blood lymphocytes in chronic HBsAg carriers.
Alexander GJ; Mondelli M; Naumov NV; Nouriaria KT; Vergani D; Lowe D; Eddleston AL; Williams R
Clin Exp Immunol; 1986 Mar; 63(3):498-507. PubMed ID: 2940037
[TBL] [Abstract][Full Text] [Related]
19. Abnormalities of B cell activation and immunoregulation in patients with chronic inflammatory liver diseases.
Sieber G; Teichmann JV; Möller B; Hopf U
Immunobiology; 1988 Dec; 178(3):215-23. PubMed ID: 3068120
[TBL] [Abstract][Full Text] [Related]
20. Immunoregulatory T subsets in chronic active viral hepatitis: characterization by monoclonal antibodies.
Pignata C; Vajro P; Troncone R; Monaco G; Ciriaco M
J Pediatr Gastroenterol Nutr; 1983 May; 2(2):229-33. PubMed ID: 6223993
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
